Cargando…
Differential gene expression induced by Verteporfin in endometrial cancer cells
Endometrial cancer (EMCA) is a clinically heterogeneous disease. Previously, we tested the efficacy of Verteporfin (VP) in EMCA cells and observed cytotoxic and anti-proliferative effects. In this study, we analyzed RNA sequencing data to investigate the comprehensive transcriptomic landscape of VP...
Autores principales: | Bang, Lisa Gahyun, Dasari, Venkata Ramesh, Kim, Dokyoon, Gogoi, Radhika P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405995/ https://www.ncbi.nlm.nih.gov/pubmed/30846786 http://dx.doi.org/10.1038/s41598-019-40495-9 |
Ejemplares similares
-
Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells
por: Dasari, Venkata Ramesh, et al.
Publicado: (2017) -
Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells
por: Dasari, Venkata Ramesh, et al.
Publicado: (2020) -
Exome-Wide Rare Variant Analysis From the DiscovEHR Study Identifies Novel Candidate Predisposition Genes for Endometrial Cancer
por: Shivakumar, Manu, et al.
Publicado: (2019) -
Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population
por: Miller, Jason E., et al.
Publicado: (2019) -
Correction to: Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population
por: Miller, Jason E., et al.
Publicado: (2019)